Clinical trials
Active, not recruiting Leukemia, Myeloid, Chronic-Phase trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| City of Hope Medical Center | 5 |
| Children's Oncology Group | 2 |
| M.D. Anderson Cancer Center | 2 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| ECOG-ACRIN Cancer Research Group | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Il-Yang Pharm. Co., Ltd. | 1 |
| Masaryk University | 1 |
| Novartis Pharmaceuticals | 1 |
| SWOG Cancer Research Network | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Chronic-Phase | 19 |
| Leukemia, Myeloid, Accelerated Phase | 8 |
| Lymphoma, Non-Hodgkin | 7 |
| Hodgkin Disease | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Myelodysplastic Syndromes | 6 |
| Primary Myelofibrosis | 6 |
| Blast Crisis | 5 |
| Myeloproliferative Disorders | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
Trials
Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.